Mode
Text Size
Log in / Sign up

Cognitive impairment affects 39% of chronic heart failure patients in pooled analysisHeart Failure Patients Face High Risk of Cognitive Impairment

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider routine cognitive screening in chronic heart failure given the 39% pooled prevalence of impairment.

This meta-analysis of 14 observational studies including 5,127 patients with chronic heart failure reports a pooled prevalence of cognitive impairment of 39.3% (95% CI: 31.0%–47.7%), representing 1,875 cases. The analysis identified 30 risk factors positively associated with cognitive impairment, including age, age ≥ 80 years, New York Heart Association (NYHA) classification, comorbidity burden, polypharmacy, malnutrition, and depression. Protective factors included higher educational attainment, engaging in physical exercise ≥ 3 times per week, and regular participation in intellectual activities.

The authors note that these findings are based on association data from observational studies and do not establish causality. The prevalence estimate is a pooled result from 14 studies with varying designs and populations. Limitations such as heterogeneity among studies were not reported in detail.

Clinically, the results suggest that cognitive impairment is common in chronic heart failure, and routine screening may be warranted. Targeted interventions addressing modifiable risk factors could potentially delay cognitive decline, though interventional studies are needed to confirm benefit.

How this fits prior evidence

This meta-analysis extends prior coverage by quantifying the prevalence of cognitive impairment in chronic heart failure, a condition not previously addressed in these items. While prior items noted associations between heart failure and insomnia, mortality risk, and cancer prevalence, this analysis adds a specific cognitive dimension. The identified risk factors (e.g., age, comorbidity) align with known predictors of poor outcomes in heart failure, reinforcing the need for comprehensive assessment.

A large review of 14 different studies involving over 5,000 patients found that nearly 40% of those living with chronic heart failure show signs of cognitive impairment. This high prevalence suggests that brain health is a significant concern for this specific group of patients.

Researchers identified several factors linked to a higher risk of these issues. These include being over age 80, having multiple other illnesses, taking many different medications at once, and experiencing depression or malnutrition. The study also noted that more complex medical classifications for heart failure were associated with higher risks.

On the other hand, some habits may help protect brain health. People who had more years of education, exercised at least three times a week, and took part in regular intellectual activities showed better outcomes. Because this was an observational review, it shows links rather than direct causes. Patients should talk to their doctors about screening for memory or thinking issues.

What this means for you:
Nearly 40% of heart failure patients have cognitive impairment; exercise and education may offer protection.

Common questions

What factors increase the risk of cognitive problems?

Several factors were linked to a higher risk, including being over age 80, having many other health conditions at once, and taking multiple medications. Depression, malnutrition, and more severe heart failure classifications also showed links to higher risks.

Are there any ways to help protect brain health?

The data suggests that certain factors may have a protective effect. These include having a higher level of education, exercising at least 3 times per week, and staying active in intellectual activities.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedJul 2026
View Original Abstract ↓
ObjectiveTo systematically investigate the prevalence and influencing factors of cognitive frailty in patients with chronic heart failure, and to provide evidence-based support for subsequent clinical intervention development.MethodsWe retrieved relevant studies focusing on the prevalence and influencing factors of cognitive frailty in patients with chronic heart failure from Embase, Cochrane Library, PubMed, Web of Science, CINAHL, SinoMed, CNKI, VIP, and Wanfang databases. The search period covered from the inception of each database to December 2025. Two researchers independently conducted study screening, data extraction, and methodological quality assessment. Meta-analysis was performed using Stata 15.0 software.ResultsFourteen studies involving 5,127 patients with chronic heart failure were included, among which 1,875 cases of cognitive frailty were reported, and 30 risk factors were identified. Meta-analysis showed that the pooled prevalence of cognitive impairment in patients with chronic heart failure was 39.3% (95% CI: 31.0%–47.7%). Further analysis identified age, age ≥ 80 years, New York Heart Association (NYHA) classification, comorbidity burden, polypharmacy, malnutrition, and depression as significant risk factors for cognitive impairment in this population. Higher educational attainment, engaging in physical exercise ≥ 3 times per week, and regular participation in intellectual activities were confirmed as protective factors against cognitive impairment in patients with chronic heart failure.ConclusionCurrent evidence confirms that cognitive impairment is highly prevalent among patients with chronic heart failure, and its occurrence is influenced by multiple modifiable and non-modifiable risk factors. Therefore, clinical healthcare providers should strengthen routine cognitive function screening for this population, and implement targeted interventions based on the identified risk factors to delay the onset of cognitive impairment and improve overall patient prognosis.Systematic Review Registrationhttps://www.crd.york.ac.uk/PROSPERO/view/CRD420251247352, PROSPERO CRD420251247352.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.